GPR68 and inflammatory bowel disease: GPR68 signalling also drives pro-inflammatory gene expression in immune and stromal cells, amplifying gut inflammation, and its expression is upregulated in colonic tissue during hypoxia.24, 25, 26 Consequently, GPR68 has emerged as a promising therapeutic target for inflammation in IBD.